Abstract
The near completion of sequencing the Candida albicans genome has made it possible to employ genomic technologies, such as microarray analysis, to aid in identifying key genes involved in such clinical problems as the acquisition of high-level resistance to azole antifungal agents. Here, we outline in detail the methodologies utilized in our laboratory to culture clinical isolates of C. albicans, isolate ribonucleic acid from such cultures, synthesize labeled complimentary deoxyribonucleic acid probes from the ribonucleic acid samples, hybridize the probes to microarray chips, analyze the data from such hybridizations, and validate results using reverse transcriptase-polymerase chain reactions. Microarray analysis gives researchers the ability to identify genes involved in processes such as acquisition of azole resistance and to use the data in a way that may lead to clinical approaches to inactivate these genes and improve patient outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feigal, D. W., Katz, M. H., Greenspan, D., et al. (1991) The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5, 519ā525.
Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M., and Friedland, G. H. (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311, 354ā358.
MorschhƤuser, J. (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587, 240ā248.
Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., and Trautmann, M. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32, 2092ā2098.
White, T. C., Marr, K. A., and Bowden, R. A. (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11, 382ā402.
Kelly, S. L., Lamb, D. C., Kelly, D. E., Loeffler, J., and Einsele, H. (1996) Letter. Lancet 348, 1523ā1524.
Kelly, S. L., Arnoldi, A., and Kelly, D. E. (1993) Molecular genetic analysis of azole antifungal mode of action. Biochem. Soc. Trans. 21, 1034ā1038.
Franz, R., Ruhnke, M., and MorschhƤuser, J. (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42, 453ā458.
Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., and MorschhƤuser, J. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42, 3065ā3072.
Sanglard, D. (2002) Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5, 379ā385.
Sanglard, D., Ischer, F., Koymans, L., and Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14-demethylase (CYP51A1) from azoleresistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42, 241ā253.
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., and Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378ā2386.
White, T. C. (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 1482ā1487.
White, T. C. (1997) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans. Antimicrob. Agents Chemother. 41, 1488ā1494.
Perea, S., Lopez-Ribot, J. L., Kirkpatrick, W. R., et al. (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45, 2676ā2684.
Lopez-Ribot, J. L., McAtee, R. K., Lee, L. N., et al. (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42, 2932ā2937.
Cowen, L. E., Nantel, A., Whiteway, M. S., et al. (2002) Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA. 99, 9284ā9289.
Rogers, P. D. and Barker, K. S. (2002) Evaluation of differential gene expression in fluconazole-susceptible and-resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob Agents Chemother. 46, 3412ā3417.
Rogers, P. D., and Barker, K. S. (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother. 47, 1220ā1227.
Rogers, P. D., Barker, K. S., and MorschhƤuser, J. (2003) Genome-wide expression profile analysis reveals genes coordinately regulated with MDR1 in association with the acquisition of fluconazole resistance in clinical isolates of Candida albicans. 15th Congress of the International Society of Human and Animal Mycology. p. 293.
Rogers, P. D., Barker, K. S., Hooshdaran, M. Z., et al. (2003) Gene expression and proteomic profile analysis reveals novel gene and protein expression patterns associated with fluconazole resistance in clinical isolates of Candida albicans. Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18, 3091ā3092.
Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95, 14,863ā14,868.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Barker, K.S., Rogers, P.D. (2005). Application of Deoxyribonucleic Acid Microarray Analysis to the Study of Azole Antifungal Resistance in Candida albicans . In: Ernst, E.J., Rogers, P.D. (eds) Antifungal Agents. Methods in Molecular Medicineā¢, vol 118. Humana Press. https://doi.org/10.1385/1-59259-943-5:045
Download citation
DOI: https://doi.org/10.1385/1-59259-943-5:045
Publisher Name: Humana Press
Print ISBN: 978-1-58829-277-3
Online ISBN: 978-1-59259-943-1
eBook Packages: Springer Protocols